M.G. Rowlands
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
- Genetics top 10%
- Estrogen and related hormone effects
Papers in
- Genetics 18
- Estrogen and related hormone effects 18
-
- Enzyme Catalysis and Immobilization 2
- Co-authors
- Michael Jarman (16 shared papers)Grace K. Poon (4 shared papers)R. Charles Coombes (5 shared papers)Mitch Dowsett (6 shared papers)Rachel Grimshaw (5 shared papers)Matthew Law (1 shared paper)Afia Zafar (1 shared paper)Rumina Hasan (1 shared paper)
- Journals
- Drug Metabolism and Disposition (4 papers)British Journal of Cancer (3 papers)FEBS Letters (1 paper)European Journal of Cancer (1 paper)Current Medicinal Chemistry (1 paper)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
M.G. Rowlands
29 papers receiving 647 citations
Peers
Comparison fields: 5 of 76
- Pharmacology 115
- Genetics 306
- Oncology 169
- Cancer Research 90
- Toxicology 17
Countries citing papers authored by M.G. Rowlands
This map shows the geographic impact of M.G. Rowlands's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.G. Rowlands with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.G. Rowlands more than expected).
Fields of papers citing papers by M.G. Rowlands
This network shows the impact of papers produced by M.G. Rowlands. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.G. Rowlands. The network helps show where M.G. Rowlands may publish in the future.
Co-authors
The 25 scholars most cited alongside M.G. Rowlands, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 88 | |
| 2 | 1993 | 79 | |
| 3 | 2007 | 66 | |
| 4 | 1994 | 51 | |
| 5 | Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis. | 1999 | 49 |
| 6 | 1996 | 39 | |
| 7 | 2001 | 38 | |
| 8 | 1998 | 34 | |
| 9 | 1994 | 29 | |
| 10 | 1988 | 29 | |
| 11 | 1996 | 25 | |
| 12 | 1991 | 25 | |
| 13 | 1984 | 19 | |
| 14 | 1995 | 18 | |
| 15 | 1996 | 18 | |
| 16 | 1989 | 15 | |
| 17 | 1992 | 11 | |
| 18 | Antiestrogens as calmodulin antagonists | 1996 | 6 |
| 19 | Selective inhibition of cholesterol side-chain cleavage by potential pro-drug forms of aminoglutethimide. | 1988 | 6 |
| 20 | Oestrogen formation in breast: clinical and biological importance. | 1996 | 5 |
About M.G. Rowlands
M.G. Rowlands is a scholar working on Genetics, Molecular Biology, Organic Chemistry, Pharmacology and Spectroscopy, having authored 30 papers that have together received 676 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (18 papers), Pharmacogenetics and Drug Metabolism (5 papers), Analytical Chemistry and Chromatography (3 papers), Hormonal and reproductive studies (3 papers), Inflammatory mediators and NSAID effects (3 papers), Cancer Cells and Metastasis (2 papers), Enzyme Catalysis and Immobilization (2 papers) and Synthesis and Reactions of Organic Compounds (2 papers). The work is most often cited by research in Pharmacology (115 citations), Genetics (306 citations), Oncology (169 citations), Cancer Research (90 citations) and Toxicology (17 citations). M.G. Rowlands has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Michael Jarman, Grace K. Poon, R. Charles Coombes, Mitch Dowsett, Rachel Grimshaw, Matthew Law, Afia Zafar, Rumina Hasan, Paul Workman and Bushra Jamil. Their work appears in journals such as Drug Metabolism and Disposition, British Journal of Cancer, FEBS Letters, European Journal of Cancer and Current Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.